Dabigatran
Subarachnoid Hemorrhage
University of EdinburghPhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 49/ 100
- Competitive Position
- 95/ 100
Competitive context
5 Active assets in the Subarachnoid Hemorrhage cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
PROPOFOL Azienda Ospedaliera San Gerardo di Monza | Phase 4 | BB |
ISOFLURANE Azienda Ospedaliera San Gerardo di Monza | Phase 4 | BB |
DICLOFENAC Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | Phase 4 | BB |
WARFARIN University of Edinburgh | Phase 3 | BB |
Edoxaban University of Edinburgh | Phase 3 | BB |
View all 24 →
Same molecule, other indications
Dabigatran is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →